IBDEI1Y8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33084,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,33084,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,33084,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,33085,0)
 ;;=R74.8^^131^1664^1
 ;;^UTILITY(U,$J,358.3,33085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33085,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,33085,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,33085,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,33086,0)
 ;;=R97.2^^131^1664^18
 ;;^UTILITY(U,$J,358.3,33086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33086,1,3,0)
 ;;=3^Elevated Prostate Specific Antigen
 ;;^UTILITY(U,$J,358.3,33086,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,33086,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,33087,0)
 ;;=R03.0^^131^1664^17
 ;;^UTILITY(U,$J,358.3,33087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33087,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,33087,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,33087,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,33088,0)
 ;;=Z91.19^^131^1664^42
 ;;^UTILITY(U,$J,358.3,33088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33088,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,33088,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,33088,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,33089,0)
 ;;=E66.01^^131^1664^43
 ;;^UTILITY(U,$J,358.3,33089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33089,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,33089,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,33089,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,33090,0)
 ;;=H93.19^^131^1664^54
 ;;^UTILITY(U,$J,358.3,33090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33090,1,3,0)
 ;;=3^Tinnitus,Unspec Ear
 ;;^UTILITY(U,$J,358.3,33090,1,4,0)
 ;;=4^H93.19
 ;;^UTILITY(U,$J,358.3,33090,2)
 ;;=^5006967
 ;;^UTILITY(U,$J,358.3,33091,0)
 ;;=G47.00^^131^1664^31
 ;;^UTILITY(U,$J,358.3,33091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33091,1,3,0)
 ;;=3^Insomnia,Unspec
 ;;^UTILITY(U,$J,358.3,33091,1,4,0)
 ;;=4^G47.00
 ;;^UTILITY(U,$J,358.3,33091,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,33092,0)
 ;;=F43.10^^131^1664^47
 ;;^UTILITY(U,$J,358.3,33092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33092,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,33092,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,33092,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,33093,0)
 ;;=F43.11^^131^1664^45
 ;;^UTILITY(U,$J,358.3,33093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33093,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,33093,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,33093,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,33094,0)
 ;;=F43.12^^131^1664^46
 ;;^UTILITY(U,$J,358.3,33094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33094,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,33094,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,33094,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,33095,0)
 ;;=I25.119^^131^1664^5
 ;;^UTILITY(U,$J,358.3,33095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33095,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,33095,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,33095,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,33096,0)
 ;;=I25.10^^131^1664^7
 ;;^UTILITY(U,$J,358.3,33096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33096,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,33096,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,33096,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,33097,0)
 ;;=I25.110^^131^1664^6
 ;;^UTILITY(U,$J,358.3,33097,1,0)
 ;;=^358.31IA^4^2
